VRAYLAR FDA approval date

The FDA approved VRAYLAR on 17 Sep 2015.

FDA approval date
17 Sep 2015

Drug identity has not yet been verified against registry records

Also recorded as CARIPRAZINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-09-17DayVRAYLARFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA204370", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VRAYLAR"], "active_ingredients": ["CARIPRAZINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150917", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026